These findings add further evidence to the promiscuity of EWSR1 in GFs in sarcomas and emphasize the value of technologies with high analytical sensitivity, such as targeted RNA-seq, to refine the classification of this heterogeneous group of entities. The gene discussed is EWSR1; the disease is sarcoma.